DID’s Benelux reader David Vandenberghe tips DID to the original RIA-Novosti report that Iran has signed a contract with China for the delivery of two squadrons (24) of its J-10 fighter planes, which are powered by Russian engines and avionics. Representatives of the Iran Aircraft Manufacturing Industrial Company said China would deliver the jets during the in 2008-2010 time frame. Novosti adds that “Experts, estimating one fighter at $40 million, put the contract’s value at $1 billion.” Iran’s most advanced fighters are currently MiG-29s, many of which once belonged to Saddam Hussein and fled to Iran during the 1991 Desert Storm war, and a handful of F-14 Tomcats that have been ingeniously maintained over the years.
The Chinese J-10 is based on plans sold by the Israelis in the 1980s, after their Lavi fighter program had been canceled. The massacre at Tiananmen Square ended cooperation with western aerospace firms, however, forcing China to install Russian AL-31FN engines instead of American F100/F110s. This in turn forced a slew of alternations owing to changes to the aircraft’s new inlet requirements, weight distribution, center of gravity, et. al. Russian avionics with their own set of space requirements also had to be installed and tested to replace American/Israeli equipment, which led to further design changes. Then there were the indigenous Chinese efforts, including the Type 1473 pulse-Doppler (PD) fire-control radar to replace Israel’s Elta or the American APG-68. The end result entered service in 2003 after well over a decade in development, and is a rather different aircraft than the Lavi. Nonetheless, it retains the aircraft’s canard-delta layout and some of its capabilities, and its aerodynamic layout and known/reported characteristics suggest an aircraft that is equal or slightly superior to American F-16 C/Ds. This could complicate Israeli strikes on targets related to Iran’s nuclear program, though many other variables would also come into play for such scenarios.
If the deal pans out at all… recent reports have thrown it into question.